SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-069196
Filing Date
2024-03-15
Accepted
2024-03-15 16:34:27
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d750149ds3.htm S-3 467044
2 EX-4.10 d750149dex410.htm EX-4.10 303540
3 EX-4.11 d750149dex411.htm EX-4.11 285842
4 EX-5.1 d750149dex51.htm EX-5.1 39857
5 EX-23.1 d750149dex231.htm EX-23.1 1690
6 EX-FILING FEES d750149dexfilingfees.htm EX-FILING FEES 72996
7 GRAPHIC g750149dsp103.jpg GRAPHIC 6511
8 GRAPHIC g750149g0311114504701.jpg GRAPHIC 1546
9 GRAPHIC g750149g35g35.jpg GRAPHIC 33177
  Complete submission text file 0001193125-24-069196.txt   1225645
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277998 | Film No.: 24755366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)